Effect of PBM on Functional Capacity and Fatigability in Post Covid-19 Elderly
A Comparative Study Between Photobiomodulation and Placebo on Functional Capacity and Fatigability in Post Covid-19 Elderly
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
group (A):
- Each participant will sign a consent form after receiving a detailed explanation about the procedure.
- submaximal exercise capacity using time up and go test will be assessed.
- fatigability will be assessed using fatigue assessment scale.
- hemodynamic variables including; Blood pressure, heart rate, oxygen saturation, maximum oxygen consumption will also be assessed.
- After one month all the assessment procedure will be repeated again.
r group (B):
- Each participant will sign a consent form after receiving a detailed explanation about the procedure.
- submaximal exercise capacity using time up and go test will be assessed.
- fatigability will be assessed using fatigue assessment scale.
- hemodynamic variables including; Blood pressure, heart rate, oxygen saturation, maximum oxygen consumption will also be assessed.
- After one month all the assessment procedure will be repeated again.
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Rana H El Banna, PHD
- Phone Number: 00201062070686
- Email: rana.elbanna@yahoo.com
Study Contact Backup
- Name: Sherif O Elabd, master
- Phone Number: 002001067227404
- Email: shiref.osama@yahoo.com
Study Locations
-
-
-
Giza, Egypt, 12613
- Recruiting
- Al Agouza Outpatient Clinic
-
Contact:
- Sherif O osama, PHD
- Phone Number: 00201067227404
- Email: shiref.elabd@yahoo.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 60 to 75 years of age
- past history of covid 19 in the last year
Exclusion Criteria:
- ( history of a histologically demonstrated malignant carcinoma , hyperthyreosis , epilepsy, light sensitivity )
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Group A
the participant will received photobiomodulation session.
|
Photobiomodulation (PBM) describes the use of red or near-infrared light to stimulate, heal, regenerate, and protect tissue that has either been injured, is degenerating, or else is at risk of dying.
|
|
Placebo Comparator: Group B
the participant will received placebo photobiomodulation session.
|
placebo intervention while the photobiomodulation device is on the off mode
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
effect of photobiomodulation on fatigability level
Time Frame: after one month of the trial application
|
fatigability level will be assessed using fatigability assesment scale
|
after one month of the trial application
|
|
effect of photobiomodulation on functional capacity level
Time Frame: after one month of the trial application
|
functional capacity state will be assessed using submaximal exercise test (time up and go test)
|
after one month of the trial application
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Rana H El Banna, PHD, Faculty of physical therapy at Cairo University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Rana H Elbanna
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.